Lite Strategy, Inc. — Director's Dealing 2025

Aug 20, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2025-08-08

Reporting Person: Riezman Joshua (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-08	Stock Option (Right to Buy)	$5.19	A	10000	Acquired	2035-08-08	Common Stock (10000)	Direct

Footnotes

F1: Such option shall vest and become exercisable in 36 equal monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.